Analyst Ratings for Pacific Biosciences of California (PACB)

PACB Rating Summary

PACB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PACB
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $36.60 (+43.1%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 38%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/11/2021 Piper Sandler William Quirk Upgrade Overweight
(Neutral)
52.00
(N/A)
45.90
(25.58)
-44.27% Details
10/2/2020 JPMorgan Tycho Peterson Upgrade Overweight
(Neutral)
15.00
(N/A)
9.87
(25.58)
159.17% Details
Like PACB Ratings? Also take a look at NVTA, MTLS, FATE, API

PACB Ratings News